
Bristol Myers Partners with Nvidia to Construct AI Factory; Samsung Biologics Makes Bid for Peptide Maker
Bristol Myers joins other pharmaceutical companies in leveraging AI technology by teaming up with Nvidia to build a new AI data center. Meanwhile, in the industry, Novartis gains an advantage in the competitive market with a kidney drug. These developments showcase the ongoing innovation and competition within the pharmaceutical sector, impacting American industry and production.












